Infosys Is the New Weight Watchers

The Indian IT industry built a $300 billion empire on human labor arbitrage. AI coding agents are the GLP-1 of that model. The difference: Infosys still has time to pivot.

Weight Watchers peaked at $100 a share in 2018 on a simple premise: human coaches and community could solve weight loss better than any alternative. Seven years later, it filed for Chapter 11 with $1.6 billion in debt, wiped out by GLP-1 drugs that solved the same problem chemically. The analogy to Indian IT is not subtle.

Infosys and Tata Consultancy Services built a combined $150 billion market cap by doing for software what WW did for dieting: deploying human beings at scale to solve a problem more cheaply than the client could. Application maintenance, testing, business process outsourcing — the $282 billion global IT services market runs on labor arbitrage. AI coding agents are the GLP-1 of that model, and the people who saw this earliest are the people worth listening to.

Vinod Khosla, who backed OpenAI at a $50 million valuation when it was a nonprofit, said in June that the Indian IT industry "will be gone" without an immediate pivot. Chris Hohn, founder of TCI Fund Management and one of the world's most aggressive activist investors, told investors that "demand for those services could collapse because AI can do coding with half the people." The market already priced this once: in February 2026, after Anthropic launched Claude Cowork, roughly $50 billion in Indian IT market value evaporated in a single week and the Nifty IT index fell 8.2%.

The Weight Watchers Parallel

WW's collapse is the textbook case of a business model rendered obsolete by a better technology. The company peaked at a $6 billion market cap in 2018 with a simple value proposition: human coaches, community support, and a points system for weight loss. GLP-1 drugs solved the same problem chemically — more effectively, with less effort. WW filed for Chapter 11 in May 2025 with $1.6 billion in debt. Its belated pivot into selling compounded GLP-1s was too little, too late. The moat was gone.

Infosys faces the same structural threat from a different technology. The evidence is piling up:

• TCS's own chairman said AI agents could become "as numerous as TCS employees" within three years. TCS has already cut 12,000 jobs and saw net headcount fall by over 23,000 in FY2026.
• Hiring data confirms the shift: AI roles in Indian IT rose 16% year over year while overall IT hiring fell 3%, according to Naukri's JobSpeak index. The industry is replacing generalists with AI specialists — fewer bodies, different skills.
• The valuation tells the story: INFY has compressed from roughly 26x trailing earnings to 15x in 18 months, far below its 5-year average of 23x. The market is pricing in a slow-motion decline.

Where the Analogy Breaks (the Investment Case)

WW had one product and one disruptor. When GLP-1 drugs solved weight loss better, the company had nothing to sell. Infosys has multiple revenue streams and is actively building the disruptor into its own offering:

• AI services revenue at 8.2% of total ($417 million in Q1 FY27) and growing. The company has 4,600 active AI projects and 500 agents built. It is not ignoring the disruption — it is deploying it.
• Fortress balance sheet: $2.56 billion in net cash, zero net debt. WW was drowning in $1.6 billion of debt when disruption hit. Infosys has the financial runway to fund the pivot.
• The "deployment" argument: Khosla himself says India's advantage is in deploying AI at scale. Someone has to wire AI into hospitals, banks, and governments — and Indian IT firms have the enterprise relationships and integration expertise to do it.

TCS is farther along. Its AI revenue hit a $2.6 billion annualized run rate in Q1 FY27, up 13.6% sequentially, and it signed an $800 million AI-led transformation mega deal with SKF. TCS announced partnerships with Anthropic (50,000 associates getting Claude licenses) and Mistral Forge. Its 24% operating margin is best in class, and its dividend of ₹12 per share was paid today.

The Numbers

Infosys just reported Q1 FY27 (ended June 30): revenue of $5.08 billion (+2.8% YoY), net income of $819 million, and an operating margin of 21.1%. The company cut its FY27 constant currency revenue growth guidance to 1.5% to 3.0% from 1.5% to 3.5%, and JP Morgan and HSBC both downgraded the stock on July 24. The street consensus is a Hold at $11.85, essentially flat from the current $11.96.

The company also named Ashiss Kumar Dash as CEO-designate, effective July 23, with a planned transition in April 2027. Succession adds execution uncertainty.

The Frame

The Weight Watchers analogy is the right risk frame — it captures what happens when a technology makes your core value proposition obsolete. But the analogy also tells you what to watch: WW filed for bankruptcy because it could not pivot. Infosys is pivoting. Whether it succeeds is the only question that matters.

At 12 times forward earnings, well below the five-year average of 23 times, the market is pricing in a slow-motion decline. That is either a steal or a warning. The legacy application maintenance business, roughly 30% to 40% of revenue, is the part most exposed to AI coding tools. If AI services revenue can outgrow the decline in traditional maintenance, the WW outcome is off the table and Infosys at 12x earnings is cheap. If AI revenue stalls while legacy revenue erodes, the analogy resolves the other way.

What to watch: Infosys Q2 FY27 results in October will be the first full quarter under the new CEO-designate and the revised guidance. The key metric is AI revenue as a share of total: if it moves from 8.2% toward 10% while overall growth holds at 2% to 3%, the pivot is working. If AI revenue stalls and legacy growth slips further, the WW parallel gets harder to dismiss.